Double-strength MDMA causing 'more mental health issues'
Experts warn powerful strains of party pills can lead to paranoia, memory loss, anxiety and depression

Stronger forms of MDMA, the active ingredient in ecstasy, are responsible for a rise in the number of people seeking medical treatment for mental health issues related to drug use, experts say.
Long-term use of the stimulant, which is popular in the rave and festival scene, can lead to paranoia, impaired memory, anxiety and depression.
"The danger is much greater now than it was in the late 1990s," drugs expert Professor Philip Murphy told the BBC.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The risk now of young people using stronger ecstasy is higher in terms of being able to regulate emotion and your ability to think clearly."
Nearly 5,000 people were admitted to hospitals in England for mental or behavioural issues related to drug use in 2014/15, an increase of 215 per cent from ten years ago, the BBC says.
A study published in April by the European Monitoring Centre for Drugs and Drug Addiction found the amount of MDMA in the average pill had doubled in recent years.
While the average strength was between 50-80mg in the 1990s and 2000s, the current is around 125mg.
"Meanwhile," says Vice, "'super pills' are coming in from the rest of Europe – most often the Netherlands – with some containing an unthinkable 270-340 mg."
As well as the increasing potency of MDMA, British drug users are also endangering themselves with the quantity they consume. Dr Adam Winstock, who runs the Global Drugs Survey, told Vice. "The average ecstasy user in the UK uses more MDMA in a session than anywhere else in the world," he said.
An Office for National Statistics report released last September said 3,346 deaths attributed to drug poisoning were registered in the UK in 2014 – the highest since records began in 1993.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
5 heavy-handed cartoons about ICE and deportation
Cartoons Artists take on international students, the Supreme Court, and more
By The Week US
-
Exploring the three great gardens of Japan
The Week Recommends Beautiful gardens are 'the stuff of Japanese landscape legends'
By The Week UK
-
Is Prince Harry owed protection?
Talking Point The Duke of Sussex claims he has been singled out for 'unjustified and inferior treatment' over decision to withdraw round-the-clock security
By The Week UK
-
Mental health: a case of overdiagnosis?
Talking Point Issues at 'the milder end of the spectrum' may be getting wrongly pathologised
By The Week UK
-
Washwood Heath: Birmingham's pioneering neighbourhood health service
In the Spotlight NHS England chair says there is a 'really good argument this is the model for the future'
By The Week UK
-
What is overdiagnosis and is it actually happening?
The Explainer Leading expert says an overcorrection is leading to health problems
By Chas Newkey-Burden, The Week UK
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US
-
The UK's first legal drug consumption room
The Explainer 'Potentially transformative moment in UK drugs policy' as The Thistle opens in Glasgow
By The Week UK
-
4 tips for navigating holiday season stress
The Week Recommends Balancing pressure and enjoying the holidays can indeed coexist
By Theara Coleman, The Week US
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US
-
The hidden cost of lead exposure on American mental health
Under The Radar Millions of mental health diagnoses have been linked to childhood lead exposure in new study
By Theara Coleman, The Week US